Skip to content

Prevention of recurrent alcoholic pancreatitis by an optimally timed personalized multidisciplinary alcohol cessation support program

Prevention of recurrent alcoholic pancreatitis by an optimally timed personalized multidisciplinary alcohol cessation support program

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22054
Enrollment
400
Registered
2020-08-20
Start date
2020-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute alcoholic pancreatitis

Interventions

The intestigational management is based on the evidence-based general practice guideline on problematic alcohol use and consists of a program with six steps during hospital admission and after dischar

Sponsors

St. Antonius Hospital, Nieuwegein
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: First episode of acute pancreatitis (according to the Revised Atlanta criteria), harmfull drinking (defined as AUDIT score>7), age of 18 or older and provided written informed consent

Exclusion criteria

Exclusion criteria: Chronic pancreatitis, indication for referral to an addiction specialized phsyician (AUDIT>15), diagnosis of any etiology other than alcoholic after standard diagnostic work-up according to the IAP/APA evidence-based guidelines

Design outcomes

Primary

MeasureTime frame
Recurrent acute alcoholic pancreatitis

Secondary

MeasureTime frame
Cessation of alcohol use (defined as a modified AUDIT score of 0 at any time point during follow-up), clinically relevant reduction of alcohol use (defined as a modified AUDIT score ranging between 1 and 7 at any time point during follow-up), clinically relevant reduction of alcohol dependence (defined as a Short Alcohol Dependence Data (SADD) score between 1 and 9 at any time during follow-up), development of chronic pancreatitis, development of alcohol-related disease (liver steatosis, liver cirrhosis), mortality, quality of life, costs

Contacts

Public ContactNoor Sissingh

Antonius Ziekenhuis

n.sissingh@antoniusziekenhuis.nl0657117637

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)